Clinical trialObservationalCompleted
An Analysis of Presentation and Outcome Following Treatment of Pancreatic Endocrine Neoplasms
A Single Centre Analysis of Clinical Characteristics and Treatment of Endocrine Pancreatic Tumours.
- Outcome
- Results posted; single-arm, no comparison
- Phase
- Observational
- Status
- Completed
- Study type
- Observational
- Start
- March 2011
- Ended
- November 2014
- Enrollment
- 40 participants
- Sites
- 0
- Primary outcomes
- Nonfunctioning and Malignant Pancreatic Endocrine Neoplasms
- Sponsor type
- Academic / other
- Results posted
- 29 April 2015
- Last update
- 29 April 2015
These fields come from the trial’s registry entry. A summary of its population, design, endpoints and results, each tied to a quote, has not been written for this trial yet.
Results
- Primary endpoint
- Results posted; single-arm, no comparisonAs posted on ClinicalTrials.gov ↗, registry record of 29 April 2015
- Primary outcome
- Nonfunctioning and Malignant Pancreatic Endocrine NeoplasmsNonfunctioning Tumours: Patients Operated for Pancreatic Endocrine Neoplasms: 28, n = 40Functioning Tumours: Patients Operated for Pancreatic Endocrine Neoplasms: 12, n = 40Benign Tumours: Patients Operated for Pancreatic Endocrine Neoplasms: 22, n = 40Malignant Tumours: Patients Operated for Pancreatic Endocrine Neoplasms: 18, n = 40Values: participantsTime frame: Each participant was followed up for a period of 5 yearsNo analysis posted for this outcome (outcome 1)
- Participants
- Patients Operated for Pancreatic Endocrine Neoplasms: 40 started, 40 completed
- Serious adverse events
- Pancreatic Endocrine Neoplasms: 6 of 40Participants with at least one serious adverse event, of those at risk, as posted
Every value is copied from the trial’s results record at ClinicalTrials.gov. “Statistically significant” describes the posted test only: it does not say which group did better, and nothing here is read from a paper.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.
Try
Source text
Brief summary public domain (ClinicalTrials.gov)
A single institutional study of Pancreatic Endocrine Neoplasms over 18 years.
Detailed description public domain (ClinicalTrials.gov)
The investigators did an analysis from a prospectively maintained database of patients who underwent pancreatic resections or nonresective procedures for neoplasms of the pancreas at Sir Ganga Ram Hospital from 1995 to 2013 and using pathological reports and preoperative CT scan as the gold standard, the investigators identified 40 patients with PENs.
Posted results (ClinicalTrials.gov registry) · primary outcome public domain (ClinicalTrials.gov)
Nonfunctioning and Malignant Pancreatic Endocrine Neoplasms [Each participant was followed up for a period of 5 years]. Number, participants. Nonfunctioning Tumours: Patients Operated for Pancreatic Endocrine Neoplasms (n=40): 28. Functioning Tumours: Patients Operated for Pancreatic Endocrine Neoplasms (n=40): 12. Benign Tumours: Patients Operated for Pancreatic Endocrine Neoplasms (n=40): 22. Malignant Tumours: Patients Operated for Pancreatic Endocrine Neoplasms (n=40): 18.